A
AFT Pharmaceuticals Ltd
NZX:AFT
AFT Pharmaceuticals Ltd
NZX:AFT
Price:
2.97 NZD
-1%
Market Closed
Updated:
May 7, 2024
AFT Pharmaceuticals Ltd
Cash from Investing Activities
|
AFT Pharmaceuticals Ltd
Cash from Investing Activities Peer Comparison
Comparables:
BLT
CBD
RUA
G
GFI
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Cash from Investing Activities
-NZ$9.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
BLIS Technologies Ltd
NZX:BLT
|
Cash from Investing Activities
-NZ$4.1m
|
CAGR 3-Years
-191%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
|
Cannasouth Ltd
NZX:CBD
|
Cash from Investing Activities
-NZ$301.6k
|
CAGR 3-Years
49%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Rua Bioscience Ltd
NZX:RUA
|
Cash from Investing Activities
NZ$6.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
Cash from Investing Activities
-NZ$643.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AFT Pharmaceuticals Ltd's Cash from Investing Activities?
Cash from Investing Activities
-9.2m
NZD
-9.2m
NZD
Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Cash from Investing Activities amounts to -9.2m NZD.
What is AFT Pharmaceuticals Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-7%
-7%
Over the last year, the Cash from Investing Activities growth was -20%. The average annual Cash from Investing Activities growth rates for AFT Pharmaceuticals Ltd have been -6% over the past three years , -7% over the past five years .
You don't have any saved screeners yet
